About Index Trending news
Analyze
Pricing
Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

Work at Eiger BioPharmaceuticals, Inc.? Add yourself to this profile

Eiger BioPharmaceuticals, Inc.

Eiger is a biopharmaceutical company developing new antiviral agents againstnovel targets in the treatment of hepatitis.
Edit Profile
More info

Elsewhere

Contributors to this profile

Companies in the same industry

myMatrixx myMatrixx 3Scan 3Scan 3P Biopharmaceuticals 3P Biopharmaceuticals Esperance Pharmaceuticals Esperance Pharmaceuticals Sirnaomics Inc Sirnaomics Inc BioMarck Pharmaceuticals BioMarck Pharmaceuticals Aptuit Aptuit Mereo BioPharma Mereo BioPharma Plex Pharmaceuticals Plex Pharmaceuticals NemaMetrix, Inc. NemaMetrix, Inc.

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
04 Jan 2017
$25,000,000
Post-IPO debt
Oxford Finance Corporation

Eiger Biopharma Completes 25 Million Debt Financing With Oxford Finance

biospace
29 Apr 2016
$3,000,000
Venture capital

SEC FORM D

sec